EMA Will Increase Fees on April 1
The European Commission has applied to increase the fees payable to EMA by 0.2%, which in line with the 2015 inflation rate.
You’ve only got another two weeks to submit applications to the European Medicines Agency (EMA) before the fees go up. The new charges for all applications except pharmacovigilance procedures will take effect on April 1.
The European Commission has applied to increase the fees payable to EMA by 0.2%, which in line with the 2015 inflation rate. EMA has said it will publish full details of the revised fees at the end of March, once the European Commission has adopted the regulation and published it in the Official Journal of the European Union and the Agency's Management Board has reached a decision on its implementation.
All applications received by March 31 will be charged at the current fee and reduction rates, according to EMA. For scientific advice and protocol assistance, the cut-off date will be the date of validation of the request for advice. For annual fees, the anniversary date defines the applicable fee and consequently any anniversary on or after April 1, 2016 will attract the new fee.
Fees charged for pharmacovigilance procedures in accordance with Regulation (EU) 658/2014 are expected to be updated from July 1, 2016.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
